Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Center for Bio-Pharmaceutical Sciences: scope and perspectives.

D D Breimer, O H Postma

    Pharmaceutisch Weekblad. Scientific Edition
    |April 26, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

    Pharmaceutical research·2013
    Same author

    Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

    Pharmaceutical research·2013
    Same author

    Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.

    Pharmaceutical research·2013
    Same author

    The metabolic formation of N-acetyl-S-2-hydroxyethyl-L-cysteine from tetradeutero-1,2-dibromoethane. relative importance of oxidation and glutathione conjugation in vivo.

    Biochemical pharmacology·2010
    Same author

    P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

    Pharmaceutical research·2001
    Same author

    Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2001

    The Center for Bio-Pharmaceutical Sciences focuses on multidisciplinary drug research and education. It fosters collaboration between academia and industry, exploring stereoisomers and endogenous compounds.

    Area of Science:

    • Biopharmaceutical Sciences
    • Drug Discovery and Development
    • Pharmacology

    Background:

    • Established in 1984, the Center for Bio-Pharmaceutical Sciences at Leiden University aims to advance drug research.
    • Focuses on multidisciplinary approaches to understand drug production, disposition, and effects.

    Purpose of the Study:

    • To conduct integrated research on drug production, disposition, and effects in humans and animals.
    • To offer Master of Science (M.Sc.) and Doctor of Philosophy (Ph.D.) teaching programs.
    • To explore stereoisomers and endogenous compounds as key research themes.

    Main Methods:

    • Multidisciplinary research involving chemistry, biology, biotechnology, and medicine.
    • Integrated research themes focusing on stereoisomers and endogenous compounds.

    Related Experiment Videos

  • Collaboration with pharmaceutical industry partners.

    • Main Results:

    • Established a center for advanced bio-pharmaceutical research and education.
    • Initiated integrated research on stereoisomers and endogenous compounds.
    • Fostered interdisciplinary collaboration and industry partnerships.

    Conclusions:

    • The Center for Bio-Pharmaceutical Sciences is dedicated to advancing drug science through multidisciplinary research and education.
    • Integrated research themes and industry collaborations are central to its mission.
    • The center aims to bridge academic research with pharmaceutical industry needs.